DiaMedica Therapeutics Inc. Common Stock DMAC
i
Market datapartial · fetched 2026-11-03T14:42:04.624Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T14:39:38.107451944Z
FundamentalsAlpha Vantage · unavailable
DiaMedica Therapeutics Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | 14.72 | 219.4% | 60.9% | 8.05 | 189.6% | 24.8% |
| 30Δ | 14.09 | 231.8% | 56.3% | 8.62 | 211.5% | 23.6% |
| 35Δ | 13.45 | 244.3% | 51.6% | 9.20 | 233.5% | 22.3% |
| 40Δ | 12.81 | 256.7% | 47.0% | 9.77 | 255.5% | 21.0% |
| 45Δ | 12.16 | 271.2% | 42.9% | 10.22 | 253.8% | 19.0% |
| 50Δ | 11.49 | 287.6% | 39.2% | 10.58 | 236.4% | 16.6% |
| 55Δ | 10.82 | 304.0% | 35.5% | 10.94 | 218.9% | 14.1% |
| 60Δ | 10.15 | 320.4% | 31.9% | 11.30 | 201.4% | 11.6% |
| 65Δ | 9.43 | 295.0% | 25.5% | 11.66 | 184.0% | 9.2% |
| 70Δ | 8.69 | 257.3% | 18.3% | 12.02 | 166.5% | 6.7% |
| 75Δ | 7.95 | 219.7% | 11.2% | 12.38 | 149.0% | 4.2% |
| 80Δ | 13.78 | 162.4% | 3.0% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- 14.72
- IV
- 219.4%
- B/E move
- 60.9%
- Pseudo strike
- 8.05
- IV
- 189.6%
- B/E move
- 24.8%
30Δ
- Pseudo strike
- 14.09
- IV
- 231.8%
- B/E move
- 56.3%
- Pseudo strike
- 8.62
- IV
- 211.5%
- B/E move
- 23.6%
35Δ
- Pseudo strike
- 13.45
- IV
- 244.3%
- B/E move
- 51.6%
- Pseudo strike
- 9.20
- IV
- 233.5%
- B/E move
- 22.3%
40Δ
- Pseudo strike
- 12.81
- IV
- 256.7%
- B/E move
- 47.0%
- Pseudo strike
- 9.77
- IV
- 255.5%
- B/E move
- 21.0%
45Δ
- Pseudo strike
- 12.16
- IV
- 271.2%
- B/E move
- 42.9%
- Pseudo strike
- 10.22
- IV
- 253.8%
- B/E move
- 19.0%
50Δ
- Pseudo strike
- 11.49
- IV
- 287.6%
- B/E move
- 39.2%
- Pseudo strike
- 10.58
- IV
- 236.4%
- B/E move
- 16.6%
55Δ
- Pseudo strike
- 10.82
- IV
- 304.0%
- B/E move
- 35.5%
- Pseudo strike
- 10.94
- IV
- 218.9%
- B/E move
- 14.1%
60Δ
- Pseudo strike
- 10.15
- IV
- 320.4%
- B/E move
- 31.9%
- Pseudo strike
- 11.30
- IV
- 201.4%
- B/E move
- 11.6%
65Δ
- Pseudo strike
- 9.43
- IV
- 295.0%
- B/E move
- 25.5%
- Pseudo strike
- 11.66
- IV
- 184.0%
- B/E move
- 9.2%
70Δ
- Pseudo strike
- 8.69
- IV
- 257.3%
- B/E move
- 18.3%
- Pseudo strike
- 12.02
- IV
- 166.5%
- B/E move
- 6.7%
75Δ
- Pseudo strike
- 7.95
- IV
- 219.7%
- B/E move
- 11.2%
- Pseudo strike
- 12.38
- IV
- 149.0%
- B/E move
- 4.2%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 13.78
- IV
- 162.4%
- B/E move
- 3.0%
Options history
Table
| Date | IV (%) |
|---|---|
| 141.70% | |
| 141.53% | |
| 125.99% | |
| 136.99% | |
| 135.30% | |
| 104.80% | |
| 105.14% | |
| 148.49% |
Biotechnology
DNA
Ginkgo Bioworks Holdings (DNA) is a pioneering force in synthetic biology, leveraging advanced genetic engineering to create customized bioengineered organisms suitable for a wide…
More →DNLI
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company is…
More →DNTH
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and…
More →DRTS
Alpha Tau Medical Ltd., a clinical-stage oncology therapies company, is engaged in the research, development, and commercialization of alpha-emitting radiation therapy (Alpha…
More →DRUG
Description unavailable
More →DSGN
Description unavailable
More →